Back to Search
Start Over
RET, ROS1 and ALK fusions in lung cancer
- Source :
- Nature Medicine. 18:378-381
- Publication Year :
- 2012
- Publisher :
- Springer Science and Business Media LLC, 2012.
-
Abstract
- Through an integrated screening system, the authors catalog ALK and ROS1 fusions in lung cancer and identify a new class of fusions involving KIF5B and RET that may represent new therapeutic targets in adenocarcinoma.
Details
- ISSN :
- 1546170X and 10788956
- Volume :
- 18
- Database :
- OpenAIRE
- Journal :
- Nature Medicine
- Accession number :
- edsair.doi...........474638a4db602c61ca329e6629670ca9
- Full Text :
- https://doi.org/10.1038/nm.2658